November 17, 2025 a 06:00 pm
WST: Fundamental Ratio Analysis - West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. is a leading provider in the design and manufacturing of containment and delivery systems for injectable drugs. With a solid market presence, it operates in multiple regions and offers innovative products enhancing drug safety and delivery efficiency.
Fundamental Rating
The latest data indicates a stable performance with room for growth in certain areas. Below is a breakdown of the current fundamental scores.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 4 | |
| Return on Assets | 5 | |
| Debt to Equity | 2 | |
| Price to Earnings | 1 | |
| Price to Book | 2 |
Historical Rating
The historical scores provide insight into how the company's fundamentals have evolved.
| Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-11-17 | 3 | 3 | 4 | 5 | 2 | 1 | 2 |
| Previous Date | 0 | 3 | 4 | 5 | 2 | 1 | 2 |
Analyst Price Targets
Analyst forecasts show a balanced approach towards stock valuation with the following range of price targets:
| High | Low | Median | Consensus |
|---|---|---|---|
| 390 | 311 | 345 | 345.2 |
Analyst Sentiment
Analysts show a favorable sentiment with a strong inclination towards 'Buy' ratings.
| Rating | Number | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 3 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
West Pharmaceutical Services, Inc. maintains a solid fundamental performance with specific areas for improvement such as price to earnings ratio. Its innovative product offerings and strong market presence in the healthcare sector position it favorably amidst competition. The current 'Buy' consensus among analysts indicates confidence in its potential for growth. While the company faces challenges related to its debt-to-equity, the overall outlook remains positive, supported by robust analyst price targets.